(Q39827892)

15 September 2017

Activity of A-56268 compared with that of erythromycin and other oral agents against aerobic and anaerobic bacteria (English)

1 reference

15 September 2017

1 reference

1 reference

Chin NX

1

1 reference

15 September 2017

Neu NM

2

1 reference

15 September 2017

Labthavikul P

3

1 reference

15 September 2017

Saha G

4

1 reference

15 September 2017

Neu HC

5

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 March 1987

1 reference

Antimicrobial Agents and Chemotherapy

15 September 2017

1 reference

15 September 2017

31

1 reference

15 September 2017

3

1 reference

15 September 2017

463-466

1 reference

In vitro evaluation of three new macrolide antimicrobial agents, RU28965, RU29065, and RU29702, and comparisons with other orally administered drugs

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174754

Erythromycin: a microbial and clinical perspective after 30 years of clinical use (2).

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174754

Effect of Several Components of Anaerobic Incubation on Antibiotic Susceptibility Test Results

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174754

In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174754

17 June 2018

Identifiers

DOI

10.1128/AAC.31.3.463

1 reference

15 September 2017

1 reference

15 September 2017

PubMed publication ID

2953303

1 reference